Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2025)
Treace Medical Concepts' Cash & Current Investments history spans 6 years, with the latest figure at $48.4 million for Q4 2025.
- For Q4 2025, Cash & Current Investments fell 36.09% year-over-year to $48.4 million; the TTM value through Dec 2025 reached $48.4 million, down 36.09%, while the annual FY2025 figure was $48.4 million, 36.09% down from the prior year.
- Cash & Current Investments reached $48.4 million in Q4 2025 per TMCI's latest filing, down from $57.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $170.7 million in Q1 2023 to a low of $16.2 million in Q1 2021.
- Average Cash & Current Investments over 5 years is $94.9 million, with a median of $98.5 million recorded in 2022.
- Peak YoY movement for Cash & Current Investments: skyrocketed 1060.81% in 2021, then crashed 38.57% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $105.8 million in 2021, then fell by 23.23% to $81.3 million in 2022, then soared by 51.62% to $123.2 million in 2023, then plummeted by 38.57% to $75.7 million in 2024, then tumbled by 36.09% to $48.4 million in 2025.
- Per Business Quant, the three most recent readings for TMCI's Cash & Current Investments are $48.4 million (Q4 2025), $57.4 million (Q3 2025), and $69.3 million (Q2 2025).